Discovery of drugs that can be expected to have “cancer genomic medicine” effects 10:19 on December 8, which remains 10%
k10012206391_201912080619_201912080624.mp4
Among the patients who have undergone genetic testing since June, “Cancer Genomic Medicine”, which examines the genes of cancer patients and selects the most appropriate drug, has found a drug that is expected to be effective. I found that it was only 10%.
“Cancer Genomics” is a new type of medicine that analyzes the genetic information of cancer cells of patients and selects the most appropriate treatment. Targeting patients who are unable to expect the effects of standard treatment, June Medical insurance application started from.
The Ministry of Health, Labor and Welfare investigated the results of genetic testing in hospitals that handle cancer genomic medicine such as core base hospitals, and received responses from 134 hospitals nationwide.
According to it, 805 patients who had undergone genetic testing using medical insurance in the five months to October, 88 of which were found to be effective, of which 10.9% I found out that I stayed at
With regard to cancer genomic medicine, experts have pointed out that even if a gene that causes cancer is found by testing, there are many cases in which no corresponding drug has been developed, and there are only a few patients who can lead to treatment. It was.
In addition, this survey revealed that there are 51 hospitals that have not started genetic testing due to lack of staff, and the problem that the system for cancer genomic medicine has not been sufficiently developed is highlighted. It was.